Repression of CTSG, ELANE and PRTN3-mediated histone H3 proteolytic cleavage promotes monocyte-to-macrophage differentiation.


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
06 2021
Historique:
received: 27 12 2019
accepted: 05 04 2021
pubmed: 22 5 2021
medline: 22 7 2021
entrez: 21 5 2021
Statut: ppublish

Résumé

Chromatin undergoes extensive reprogramming during immune cell differentiation. Here we report the repression of controlled histone H3 amino terminus proteolytic cleavage (H3ΔN) during monocyte-to-macrophage development. This abundant histone mark in human peripheral blood monocytes is catalyzed by neutrophil serine proteases (NSPs) cathepsin G, neutrophil elastase and proteinase 3. NSPs are repressed as monocytes mature into macrophages. Integrative epigenomic analysis reveals widespread H3ΔN distribution across the genome in a monocytic cell line and primary monocytes, which becomes largely undetectable in fully differentiated macrophages. H3ΔN is enriched at permissive chromatin and actively transcribed genes. Simultaneous NSP depletion in monocytic cells results in H3ΔN loss and further increase in chromatin accessibility, which likely primes the chromatin for gene expression reprogramming. Importantly, H3ΔN is reduced in monocytes from patients with systemic juvenile idiopathic arthritis, an autoinflammatory disease with prominent macrophage involvement. Overall, we uncover an epigenetic mechanism that primes the chromatin to facilitate macrophage development.

Identifiants

pubmed: 34017121
doi: 10.1038/s41590-021-00928-y
pii: 10.1038/s41590-021-00928-y
pmc: PMC8159908
mid: NIHMS1690831
doi:

Substances chimiques

Chromatin 0
Histones 0
Recombinant Proteins 0
CTSG protein, human EC 3.4.21.20
Cathepsin G EC 3.4.21.20
ELANE protein, human EC 3.4.21.37
Leukocyte Elastase EC 3.4.21.37
Myeloblastin EC 3.4.21.76

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

711-722

Subventions

Organisme : NIAMS NIH HHS
ID : K08 AR073339
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009302
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI125197
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR059049
Pays : United States
Organisme : NIAMS NIH HHS
ID : T32 AR069512
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI110491
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR070549
Pays : United States
Organisme : NIAMS NIH HHS
ID : K08 AR072075
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR061297
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR073201
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI057229
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR070253
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM139569
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI109662
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Mol Cell. 2011 May 6;42(3):330-41
pubmed: 21549310
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Ann Rheum Dis. 2011 May;70(5):747-54
pubmed: 21173013
Mol Cell Biol. 2001 Aug;21(16):5396-407
pubmed: 11463822
Gene. 2005 Aug 15;356:193-202
pubmed: 16019164
Genes Dev. 2016 Jan 15;30(2):208-19
pubmed: 26744418
J Biol Chem. 1993 Feb 5;268(4):2458-67
pubmed: 8428921
Science. 2016 Apr 22;352(6284):aaf1098
pubmed: 27102489
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Proc Natl Acad Sci U S A. 2005 May 3;102(18):6344-9
pubmed: 15851689
Nat Genet. 2018 Dec;50(12):1716-1727
pubmed: 30397336
Cell. 2007 Feb 23;128(4):693-705
pubmed: 17320507
Nat Struct Mol Biol. 2009 Jan;16(1):17-22
pubmed: 19079264
Cell. 2008 Oct 17;135(2):284-94
pubmed: 18957203
Arthritis Rheum. 2007 Nov;56(11):3793-804
pubmed: 17968951
Biochemistry. 2001 Dec 25;40(51):15762-70
pubmed: 11747453
Biochem J. 1992 Jul 15;285 ( Pt 2):495-502
pubmed: 1637341
Nat Immunol. 2000 Dec;1(6):510-4
pubmed: 11101873
Blood. 1993 Mar 15;81(6):1607-13
pubmed: 7680921
Trends Cell Biol. 2017 Jul;27(7):527-540
pubmed: 28268050
Bioessays. 2015 Jan;37(1):70-9
pubmed: 25350939
Genome Biol. 2014;15(12):550
pubmed: 25516281
BMC Bioinformatics. 2014 Jun 12;15:182
pubmed: 24925680
Cell. 2016 Nov 17;167(5):1354-1368.e14
pubmed: 27863248
Arthritis Care Res (Hoboken). 2018 Mar;70(3):409-419
pubmed: 28499329
Sci Rep. 2019 Feb 13;9(1):1925
pubmed: 30760760
Science. 2014 Sep 26;345(6204):1251086
pubmed: 25258085
FEBS Open Bio. 2013 Aug 22;3:363-9
pubmed: 24251097
Curr Protoc Mol Biol. 2015 Jan 05;109:21.29.1-21.29.9
pubmed: 25559105
J Immunol. 2006 Nov 15;177(10):7303-11
pubmed: 17082649
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3505-10
pubmed: 20133674
Blood. 2010 Oct 21;116(16):e74-80
pubmed: 20628149
Trends Immunol. 2002 Nov;23(11):549-55
pubmed: 12401408
J Biol Chem. 1993 Jun 15;268(17):12744-8
pubmed: 8509409
Clin Immunol. 2018 Nov;196:40-48
pubmed: 29960011
Cell. 2007 May 18;129(4):823-37
pubmed: 17512414
N Engl J Med. 2012 Dec 20;367(25):2396-406
pubmed: 23252526
Ann Rheum Dis. 2016 Mar;75(3):481-9
pubmed: 26865703
Curr Opin Rheumatol. 2010 Sep;22(5):561-6
pubmed: 20517154
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Nat Rev Rheumatol. 2011 Jun 07;7(7):416-26
pubmed: 21647204
Cell. 2007 Mar 9;128(5):1003-12
pubmed: 17350582
Bio Protoc. 2017 Mar 20;7(6):
pubmed: 28845440
Immunobiology. 2005;210(2-4):153-60
pubmed: 16164022
Science. 2018 Oct 26;362(6413):
pubmed: 30361341
Proc Natl Acad Sci U S A. 2011 May 31;108(22):E149-58
pubmed: 21551099
N Engl J Med. 2012 Dec 20;367(25):2385-95
pubmed: 23252525
PLoS One. 2014 Jul 23;9(7):e103230
pubmed: 25054204
Mol Cell Biol. 2000 Nov;20(22):8602-12
pubmed: 11046155
Stem Cells. 2007 Apr;25(4):1037-46
pubmed: 17272500
J Exp Med. 2005 Oct 3;202(7):955-65
pubmed: 16203866
Cell. 2018 May 31;173(6):1385-1397.e14
pubmed: 29706550
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Nat Rev Rheumatol. 2019 Jun;15(6):340-354
pubmed: 31065108
PLoS One. 2014 Feb 28;9(2):e90496
pubmed: 24587380
Pharmacol Rev. 2010 Dec;62(4):726-59
pubmed: 21079042
Cell. 2012 Sep 28;151(1):181-93
pubmed: 23021224
Methods Enzymol. 1999;304:3-19
pubmed: 10372352

Auteurs

Peggie Cheung (P)

Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Steven Schaffert (S)

Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Center for Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Sarah E Chang (SE)

Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Mai Dvorak (M)

Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Michele Donato (M)

Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Center for Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Claudia Macaubas (C)

Program in Immunology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.

Mariko H Foecke (MH)

Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Tie-Mei Li (TM)

Department of Biology, Stanford University, Stanford, CA, USA.

Lichao Zhang (L)

Chan Zuckerberg Biohub, Stanford, CA, USA.

John P Coan (JP)

Department of Biology, Stanford University, Stanford, CA, USA.

Grant S Schulert (GS)

Division of Rheumatology, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Alexei A Grom (AA)

Division of Rheumatology, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Lauren A Henderson (LA)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Peter A Nigrovic (PA)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Joshua E Elias (JE)

Chan Zuckerberg Biohub, Stanford, CA, USA.

Or Gozani (O)

Department of Biology, Stanford University, Stanford, CA, USA.

Elizabeth D Mellins (ED)

Program in Immunology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. mellins@stanford.edu.

Purvesh Khatri (P)

Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA. pkhatri@stanford.edu.
Center for Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. pkhatri@stanford.edu.

Paul J Utz (PJ)

Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA. pjutz@stanford.edu.
Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. pjutz@stanford.edu.

Alex J Kuo (AJ)

Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA. alexjkuo0229@gmail.com.
Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. alexjkuo0229@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH